Media and Content Manager, Telethon Kids Institute
| Role | Organisation | Sources |
|---|---|---|
| Media and Content Manager | Telethon Kids Institute | Brandon Capital, Brandon BioCatalyst |
Stories naming Simone Knox. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
A Telethon Kids spin-out backed by Brandon Capital has begun trials in the US and Australia of RSP-1502, an inhaled antibiotic booster for cystic fibrosis lung infections, after strong early results in WA patients.
A Telethon Kids offshoot, Respirion Pharmaceuticals, is trialling its antibiotic-booster therapy RSP-1502 in the US and Australia, with backing from Brandon Capital and an American cystic fibrosis foundation.